EXANE DERIVATIVES - BIONTECH SE ownership

BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of BIONTECH SE
ValueSharesWeighting
Q2 2022$119,112,000
-0.8%
799
+13.5%
0.07%
+100.0%
Q1 2022$120,068,000
-21.9%
704
+18.1%
0.03%
-8.1%
Q4 2021$153,643,000
+5.6%
596
+11.8%
0.04%
+5.7%
Q3 2021$145,499,000
+101.2%
533
+53.2%
0.04%
+118.8%
Q2 2021$72,327,000
-32.3%
348
-64.4%
0.02%
-48.4%
Q1 2021$106,783,000
+33.9%
9780.0%0.03%
+34.8%
Q4 2020$79,723,0009780.02%
Other shareholders
BIONTECH SE shareholders Q2 2022
NameSharesValueWeighting ↓
Fosun International Ltd 1,580,777$407,524,00023.29%
Bill & Melinda Gates Foundation 148,674$38,300,00011.62%
Pendal Group Ltd 1,955,940$504,241,0004.04%
Darwin Global Management, Ltd. 90,057$23,217,0003.55%
Connective Portfolio Management, LLC 7,460$1,923,0003.38%
Baader Bank Aktiengesellschaft 157,160$40,509,0003.11%
PARUS FINANCE (UK) Ltd 32,754$8,444,0002.71%
MARK ASSET MANAGEMENT LP 89,942$23,187,0002.64%
ELEMENT CAPITAL MANAGEMENT LLC 155,607$40,115,0002.58%
Renaissance Capital LLC 32,829$8,463,0002.17%
View complete list of BIONTECH SE shareholders